-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PYX-201 in Metastatic Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PYX-201 in Metastatic Breast Cancer Drug Details: PYX-201 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Metastatic Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Metastatic Pancreatic Cancer Drug Details: BMS-813160 is under development for solid tumor, metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Metastatic Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Metastatic Ovarian Cancer Drug Details: IPI-549 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Human in Type 2 Diabetes
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Insulin human in Type 2 Diabetes Drug Details:Insulin human (oral HDV-Insulin) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Human in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Insulin human in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Insulin human (oral HDV-Insulin) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Injectable Hdv Mealtime Insulin For Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Injectable Hdv Mealtime Insulin For Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Recombinant...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tarloxotinib Bromide in Squamous Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Tarloxotinib Bromide in Squamous Non-Small Cell Lung Cancer Drug Details:Tarloxotinib bromide is under development for treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Injectable Hdv Basal Insulin For Type 1 And Type 2 Diabetes in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Injectable Hdv Basal Insulin For Type 1 And Type 2 Diabetes in Type 1 Diabetes (Juvenile...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Injectable Hdv Basal Insulin For Type 1 And Type 2 Diabetes in Type 2 Diabetes
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Injectable Hdv Basal Insulin For Type 1 And Type 2 Diabetes in Type 2 Diabetes Drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ulixertinib in Esophageal Squamous Cell Carcinoma (ESCC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ulixertinib in Esophageal Squamous Cell Carcinoma (ESCC) Drug Details:Ulixertinib (BVD-523) is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.